Avinoam Dukler, PhD

Dr. Avi Dukler is an entrepreneur and executive with global experience in strategy, product development, commercialization, reimbursements, and general management of worldwide teams, including Israel, Europe, and the US. Avi has managed biomarkers’ discovery, clinical development, and regulation and commercialization of two personalized medicine clinical diagnostic products. In his current role, Avi is the Managing Partner and President of Glycominds, LLC, a company that discovers, develops, and commercializes specialty high value clinical tests for inflammatory bowel diseases. Avi is also the Co-Founder and CEO of Kepler Diagnostics, Inc., an early-stage company with the mission to decentralize diagnostics and remote testing by using its proprietary Samplla device for at-home specimen collection. Avi has a PhD in Biotechnology from Tel Aviv University and is an inventor in multiple issue patents in the field.